Following encouraging clinical data , retatrutide, a novel peptide therapy for treating adult-onset hyperglycemia , has received regulatory approval from Great Britain's Drug and Regulatory Agency (MHRA https://shopretatrutidepeptide.com/category/retatrutide-peptide/